Neurotoxicology and teratology
-
Neurotoxicol Teratol · Sep 1987
Clinical Trial Controlled Clinical TrialAbsence of symptoms with carboxyhemoglobin levels of 16-23%.
It has been generally accepted that carboxyhemoglobin levels between 10-20% produce mild headaches, dizziness and/or nausea. Experimental double blind exposures of 18 healthy, nonsmoking young men at rest to 7,000-24,000 ppm CO, designed to elevate COHb to 15-20% in 3-5 minutes, were followed by exposure to 232 ppm CO designed to maintain COHb level for a total of 130 minutes. ⋯ Subjects were especially queried about headache, dizziness and nausea. The symptoms which were previously reported in clinical studies of CO poisoning may have resulted from CO exposure in combination with (a) exposure to other substances, (b) stress due to the event that precipitated medical attention or (c) higher COHb levels before the first blood sample was taken.